Login / Signup
Bo Dai
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 4
Top Topics
Natural Killer Cells
Nk Cells
Histone Deacetylase
Chemotherapy Induced
Top Venues
Cancer research
Cell death and differentiation
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jiayan Zhu
,
Feng Wang
,
Lining Wang
,
Bo Dai
,
Guilin Xu
,
Luyao Zhao
,
Huimin Jiang
,
Wenhui Gao
,
Tingting Zhang
,
Chenxi Zhao
,
Yun-Xuan Li
,
Jiong Hu
,
Ke Li
HDAC Inhibition Increases CXCL12 Secretion to Recruit Natural Killer Cells in Peripheral T Cell Lymphoma.
Cancer research
(2024)
Jiayan Zhu
,
Feng Wang
,
Lining Wang
,
Bo Dai
,
Guilin Xu
,
Luyao Zhao
,
Huimin Jiang
,
Wenhui Gao
,
Tingting Zhang
,
Chenxi Zhao
,
Yun-Xuan Li
,
Jiong Hu
,
Ke Li
HDAC Inhibition Increases CXCL12 Secretion to Recruit Natural Killer Cells in Peripheral T-cell Lymphoma.
Cancer research
84 (15) (2024)
Bo Dai
,
Feng Wang
,
Ying Wang
,
Jiayan Zhu
,
Yunxuan Li
,
Tingting Zhang
,
Luyao Zhao
,
Lining Wang
,
Wenhui Gao
,
Junmin Li
,
Honghu Zhu
,
Ke Li
,
Jiong Hu
Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα.
Cell death and differentiation
(2023)
Kun Chang
,
Yingji Chen
,
Xuanzhi Zhang
,
Wei Zhang
,
Ning Xu
,
Bohan Zeng
,
Yue Wang
,
Tao Feng
,
Bo Dai
,
Fu-Jiang Xu
,
Dingwei Ye
,
Chenji Wang
DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Cancer research
(2023)